INmune Bio

-$0.56 (-3.81%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.

About INMB

INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimer’s disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE.

CEO
Raymond J. Tesi
Employees
5
Headquarters
La Jolla, California
Founded
2015

INMB Key Statistics

Market Cap
249.52M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
722.44K
High Today
$15.52
Low Today
$13.90
Open Price
$14.60
Volume
631.92K
52 Week High
$29.99
52 Week Low
$7.28

INMB Earnings

-$0.44
-$0.29
-$0.15
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
-$0.34 per share
Actual
-$0.44 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure